FDA panel to discuss cethromycin

FDA's Anti-Infective Drugs Advisory Committee will meet on June 2 to discuss an NDA from Advanced Life Sciences (NASDAQ:ADLS) for cethromycin to treat mild to moderate community-acquired pneumonia (CA...